Hosted on MSN19h
Gilead’s lenacapavir applications for HIV gain EMA validation
Gilead Sciences has announced the European Medicines Agency’s (EMA) validation for a parallel accelerated review of ...
Here are highlights from Tuesday’s Analyst Blog:
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
Trump’s Funding Cuts Halt Rollout Of HIV Prevention Drug
A groundbreaking injectable designed to curb the global spread of HIV is now at risk of being delayed due to Donald Trump's ...
Morgan Stanley sees FDA approval of GILD's Lenacapavir
Morgan Stanley expects the FDA to approve Gilead Sciences (NASDAQ:GILD)' Lenacapavir (LEN) for HIV prevention (PrEP) on or before its June 19 PDUFA date, a move that the bank believes could drive ...
Something Unexpected Is Spewing Stars Into the Milky Way
Fast-moving stars in the Milky Way indicate there could be a supermassive black hole in the neighboring Large Magellanic ...
Zacks.com on MSN1h
Biotech Stock Roundup: BLUE Down on Update, News From GILD, TRDA
It was a busy week for the biotech sector. While the fourth-quarter earnings season is nearing the end, other pipeline and ...
Costa Rica Is Saving Forest Ecosystems by Listening to Them
Monitoring the noises within ecosystems reveals their health—allowing researchers to monitor changes in biodiversity, detect ...
Healio22h
Top in ID: Undetected bird flu cases in veterinarians; CDC officers remain in positions
Three bovine veterinarians had undetected H5N1 avian influenza infections despite no apparent contact with infected cows, ...